Human IgG Antibodies to Pseudomonas aeruginosa Core Lipopolysaccharide Determinants are Detected in Chronic but not Acute Pseudomonas Infection

References

• Johns M, Skehill A, McCabe W R. Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. J Infect Dis 1983; 147: 57–67
   Google Scholar
• Teng N NH, Kaplan H S, Hebert J M, Moore C, Douglas H, Wunderlich A, Braude A I. Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci USA 1985; 82: 1790–1794
   PubMed Web of Science ®Google Scholar
• Braude A I, Ziegler E J, McCutchan J A, Douglas H. Immunization against nosocomial infection. Am J Med 1981; 70: 463–466
   PubMedGoogle Scholar
• Ziegler E J, McCutchan J A, Fierer J, Glauser M P, Sadoff J C, Douglas H, Braude A I. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1982; 307: 1225–1230
   PubMed Web of Science ®Google Scholar
• Zinner S H, McCabe W R. Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. J Infect Dis 1976; 133: 37–45
   PubMed Web of Science ®Google Scholar
• Pollack M, Huang A I, Prescott R K, Young L S, Hunter K W, Cruess D F, Tsai C M. Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to Escherichia coli endotoxin core. J Clin Invest 1983; 72: 1874–1881
   PubMedGoogle Scholar
• Wilkinson S G. Composition and structure of lipopolysaccharides from Pseudomonas aeruginosa. Rev Infect Dis 1983; 55: 941–949
   Google Scholar
• Kropinski A M, Jewell B, Kuzio J, Milazzo F, Berry D. Structure and functions of Pseudomonas aeruginosa lipopolysaccharides. Antibiot Chemother 1985; 36: 58–73
   PubMedGoogle Scholar
• Koval S F, Meadow P M. The isolation and characterization of lipopolysaccharide-defective mutants of Pseudomonas aeruginosa. J Gen Microbiol 1977; 98: 387–398
   PubMedGoogle Scholar
• Rowe P S, Meadow P M. Structure of the core oligosaccharide of Pseudomonas aeruginosa PACIR and its defective mutants. Eur J Biochem 1983; 132: 329–337
   PubMedGoogle Scholar
• Meadow P M, Rowe P S, Wells P L. Characterization of polyagglutinating and surface antigens in Pseudomonas aeruginosa. J Gen Microbiol 1984; 130: 631–644
   PubMedGoogle Scholar
• Gascon R, Adamu S, Bermudez L E, Lancero M, Young L S. Functional activity of monoclonal antibody against common core lipopolysaccaride antigen of P. aeruginosa. Program and Abstract of the 25th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Minneapolis 1985, Abstract 77
   Google Scholar
• Darveau R P, Hancock R EW. Procedure for isolation of bacterial lipopolysaccaride from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 1983; 155: 831–838
   PubMed Web of Science ®Google Scholar
• Hames B D. An introduction to polyacrylamide gel electrophoresis. Gel electrophoresis of proteins: a practical approach, B D Hames, D Rickwood. IRL Press, Oxford, England 1981; 1–93
   Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Hitchcock P J, Brown T M. Morphological heterogeneity among Salmonella lipopolysaccaride chemotypes in silver-stained polyacrylamide gels. J Bacteriol 1983; 154: 269–277
   PubMed Web of Science ®Google Scholar
• Caldwell H D, Hitchcock P J. Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccaride. Infect Immun 1984; 44: 306–314
   PubMedGoogle Scholar
• McCabe W R, Kreger B F, Johns M. Type specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med 1972; 287: 261–267
   PubMed Web of Science ®Google Scholar
• Hancock R EW, Mutheria L M, Chan L, Darveau R P, Speert D P, Pier G B. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccaride O side chains. Infect Immun 1983; 42: 170–177
   PubMed Web of Science ®Google Scholar
• Sadoff J C, Wright D C, Futrovsky S, Sidberry H, Collins H, Kaufmann B. Characterization of mouse monoclonal antibodies directed against Pseudomonas aeruginosa lipopolysaccarides. Anti-biot Chemother 1985; 36: 134–146
   PubMedGoogle Scholar
• Engels W, Endert J, Kamps M A, van Boven C P. Role of lipopolysaccaride in opsonization and phagocytosis of Pseudomonas aeruginosa. Infect Immun 1985; 49: 182–189
   PubMed Web of Science ®Google Scholar
• Tahara T, Wilkinson S G. The lipopolysaccaride from Pseudomonas aeruginosa NCTC 8505: structure of the O-specific polysaccaride. Eur J Biochem 1983; 134: 299–304
   PubMedGoogle Scholar
• Diaz F, Mosovich L L, Neter E. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis. J Infect Dis 1970; 121: 269–274
   PubMedGoogle Scholar
• Hancock R EW, Mouat E CA, Speert D P. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. J Infect Dis 1984; 149: 220–226
   PubMedGoogle Scholar
• Young L S, Meyer R D, Amstrong D. Pseudomonas aeruginosa vaccine in cancer patients. Ann Intern Med 1973; 79: 518–527
   PubMedGoogle Scholar
• Jones R J, Roe E A, Gupta J C. Low mortality in burned patients in a Pseudomonas vaccine trial. Lancet 1978; 2: 401–403
   PubMed Web of Science ®Google Scholar
• Braude A I, Douglas H, Davis C E. Treatment and prevention of intravascular coagulation with antiserum to endotoxin. J Infect Dis 1973; 128: S157–S164
   Google Scholar